Zobrazeno 1 - 4
of 4
pro vyhledávání: '"M. S. Lem"'
Publikováno v:
Acta Horticulturae. :19-24
CHARACTERISTICS OF OLOKIZUMAB PHARMACOKINETICS IN PATIENTS WITH NOVEL CORONAVIRUS INFECTION COVID-19
Autor:
E. V. Tavlueva, E. V. Zernova, M. P. Kutepova, N. E. Kostina, V. S. Lesina, D. R. Mould, K. Ito, A. V. Zinchenko, A. N. Dolgorukova, M. V. Nikolskaya, M. S. Lemak, O. V. Filon, M. Yu. Samsonov
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 10, Iss 5, Pp 460-471 (2022)
The aim of the article is to study pharmacokinetic characteristics of intravenous olokizumab in patients with moderate COVID-19 to relieve a hyperinflammation syndrome.Materials and methods. The pharmacokinetic study was conducted as a part of a phas
Externí odkaz:
https://doaj.org/article/96b8864adb544463a121630b4d6598a5
Autor:
E. V. Shipaeva, O. V. Filon, A. V. Zintchenko, G. A. Shipunov, A. A. Dmitrieva, M. S. Lemak, S. A. Grishin, E. I. Trofimets, K. L. Kryshen, L. I. Kozlovskaya, A. S. Lunin, V. D. Apolokhov, S. F. Barbashov, Ya. V. Lavrovsky, M. Yu. Samsonov
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 22, Iss 4, Pp 414-434 (2022)
Finding effective and safe medicines to fight SARS-CoV-2 infection is an urgent task. RPH-137 is an original trap fusion protein against SARS-CoV-2 virus. It comprises the angiotensin-converting enzyme type 2 extracellular domain and the human IgG1 F
Externí odkaz:
https://doaj.org/article/b6498fb9f9704919973eae259a4a5c4e
Autor:
M. Ribeiro, S. N. G. Socoloski, C. M. Komiyama, M. S. Lemos, J. C. O. Silva, R. P. Ribeiro, M. B. Vendramel, E. C. Reginato, T. B. Vieira
Publikováno v:
Scientific Electronic Archives, Vol 8, Iss 3, Pp 61-65 (2015)
The eggs, when manipulated in inadequate sanitary conditions, are considered as ways for development and multiplication of spoilage and pathogenic microorganisms. Thus, the objective was to evaluate the microbiological quality of eggs marketed out at
Externí odkaz:
https://doaj.org/article/1ebd3dceb7f54794a4d1b8976e06a8ff